I Don’t Think It’s Myocarditis, I Think It’s Injection-Induced Cardiac Amyloidosis
Jessica Rose Cardiac Amyloidosis or Stiff Heart Syndrome is caused by deposits of abnormal proteins in the heart tissue. This results in the heart ceasing to function properly due to the replacement of normal heart muscle tissue with amyloids. Cardiac Amyloidosis is associated with thick heart walls and large atria. It can affect electrical conductivity […]
Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials
Joseph Fraiman et al. Pfizer and Moderna mRNA COVID-19 vaccines were associated with an increased risk of serious adverse events of special interest, with an absolute risk increase of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95% CI -0.4 to 20.6 and -3.6 to 33.8), respectively. Combined, the mRNA […]
An Incredible Paper Was Just Published: It’s Incredible in Terrifying ways
Jessica Rose The bottom line of this incredible work is that there are two amyloidogenic proteins in the Open Reading Frames (ORF) 6 and 10 from SARS-nCoV-2 (the ORF-10 one does not have a homologue in SARS-nCoV – that means it’s unique to SARS-nCoV-2), that form crystalline amyloid structures independently, and together, at room temperature!, […]
Neurotoxic Amyloidogenic Peptides in the Proteome of SARS-COV2: Potential Complications for Neurological Symptoms in COVID-19
Mirren Charnley et al. COVID-19 is primarily known as a respiratory disease caused by SARS-CoV-2. However, neurological symptoms such as memory loss, sensory confusion, severe headaches, and even stroke are reported in up to 30% of cases and can persist even after the infection is over (long COVID). These neurological symptoms are thought to be […]
FDA Unanimously Approve Covid Vaccine for 0-4 Years: Unfathomable Decision Given the Trial Data
Health Advisory & Recovery Team (HART) It was depressing that in the FDA open meeting, none of the members pointed out that 2 months follow-up is totally inadequate for assessing safety, nor questioned the use of an antibody level as a measure of success. … Moderna was also authorised for children at the same meeting, despite several countries having dropped it […]
Asymptomatic Spread: Who Can Really Spread COVID-19?
John Lee A respiratory virus needs associated symptoms in order to be clinically relevant. One year ago, this belief would have been universally accepted by the wider medical community. The response to COVID-19 has been predicated on the assumption that asymptomatic PCR positive individuals can spread disease. This assumption was simply accepted as fact and, […]
First Finding From Pfizer
Health Advisory & Recovery Team (HART) … Early analysis has demonstrated several concerning anomalies but crucially it has revealed that the efficacy data was not what was sold. … Pfizer set out in its protocol that efficacy would be measured based on PCR positive test results in symptomatic individuals and, as a secondary measure, N-antibody […]
New FOIA Release Shows CDC Lied About Its VAERS Safety Monitoring Efforts
Josh Guetzkow They never found any safety signals, because they didn’t look for them. … They said they were going to use the most basic, standard pharmacovigilance method by calculating what are called proportional reporting ratios (PRR’s) to monitor VAERS (see the article linked above for more details). But it turns out they didn’t. And […]
